Edwards Lifesciences EW Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Net Sales by Business | |||||
| Europe | $1.52B+14.8% | $1.32B+8.1% | $1.22B+17.5% | $1.04B-5.4% | |
| Japan | $354.7M+4.4% | $339.8M-9.6% | $376M— | —— | |
| Rest of World | $652.3M+14.0% | $572M-0.2% | $573M+27.6% | $449.1M-15.8% | |
| United States | $3.54B+10.5% | $3.21B+3.7% | $3.09B+17.6% | $2.63B-11.3% | |
| Net Sales by Product | |||||
| Transcatheter Aortic Valve Replacement | $4.49B+9.3% | $4.11B+5.8% | $3.88B+10.3% | $3.52B+2.8% | |
| Transcatheter Mitral and Tricuspid Therapies | $550.6M+56.4% | $352.1M+78.2% | $197.6M+70.2% | $116.1M+35.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Edwards Lifesciences break its business down?
- Edwards Lifesciences (EW) reports net sales by business across 4 parts — Europe, Japan, Rest of World and United States. Each is extracted from the segment footnotes and tracked over time.
- Where does Edwards Lifesciences's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Edwards Lifesciences's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
